Holen Sie sich die Stockscreener-App
33.28
1.89%
-0.64
Handel nachbörslich:
33.27
-0.010
-0.03%
Schlusskurs vom Vortag:
$33.92
Offen:
$34.45
24-Stunden-Volumen:
1.17M
Relative Volume:
1.53
Marktkapitalisierung:
$1.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.31%
1M Leistung:
-26.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$32.50
$35.41
1-Wochen-Bereich:
$32.50
$37.31
52-Wochen-Spanne:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Firmenname
First Tracks Biotherapeutics Inc
Sektor
Branche
Telefon
212-373-3000
Adresse
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
33.28 | 1.23B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-24 | Eingeleitet | Leerink Partners | Outperform |
| 2026-04-24 | Eingeleitet | Wedbush | Outperform |
| 2026-04-23 | Eingeleitet | JP Morgan | Overweight |
| 2026-04-22 | Eingeleitet | Barclays | Overweight |
| 2026-04-21 | Eingeleitet | UBS | Buy |
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
CCORF Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $50 - Moomoo
First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rated "Buy" in New Coverage at Canaccord Genuity Group - MarketBeat
Canaccord initiates First Tracks Biotherapeutics stock with buy By Investing.com - Investing.com South Africa
Canaccord initiates First Tracks Biotherapeutics stock with buy - Investing.com
First Tracks Biotherapeutics Inc Cash Flow – GETTEX:B43 - TradingView
First Tracks Biotherapeutics, Inc. (TRAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Tracks Biotherapeutics Inc Balance Sheet – MUN:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – MUN:B43 - TradingView
Debt to assets ratio of First Tracks Biotherapeutics Inc – GETTEX:A428R1 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – GETTEX:A428R1 - TradingView
State Street Corp Buys 1,512,896 Shares of First Tracks Biotherapeutics $TRAX - MarketBeat
AnaptysBio : Annual Transition Report (Form 10-KT) - marketscreener.com
Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan
Anaptys Announces Second Quarter and Transitional Fiscal - GlobeNewswire
Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - Moomoo
John Orwin (TRAX) lifts direct stake to 17,995 shares - Stock Titan
First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rating Upgraded by Guggenheim - marketbeat.com
First Tracks Biotherapeutics stock rises on Guggenheim buy rating By Investing.com - Investing.com India
Why is First Tracks Biotherapeutics stock rallying today? By Investing.com - Investing.com Canada
First Tracks Biotherapeutics stock rises on Guggenheim buy rating - Investing.com
Guggenheim initiates coverage of First Tracks with Buy rating, $100 price target - TradingView
Guggenheim initiates First Tracks stock with buy on autoimmune drug potential - Investing.com Canada
First Tracks Biotherapeutics Inc Actuals & Estimates (NASDAQ:TRAX) - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics Inc – FWB:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – FWB:B43 - TradingView
ETFs Investing in First Tracks Biotherapeutics Inc Stocks - TradingView
First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics Insider Ware J. Anthony Sells 39,265 Shares at $44.78 Following Option Exercise - Kalkine Media
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Dell, Gitlab surge 11-14% on strong Q2 results; Sirius XM rises - scanx.trade
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Revenue per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Tangible book value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Return on assets % of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to book ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Yahoo Finance
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Finanzdaten der First Tracks Biotherapeutics Inc-Aktie (TRAX)
Es liegen keine Finanzdaten für First Tracks Biotherapeutics Inc (TRAX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
First Tracks Biotherapeutics Inc-Aktie (TRAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ware J. Anthony | Director |
Sep 02 '26 |
Option Exercise |
5.74 |
39,265 |
225,381 |
54,925 |
| Ware J. Anthony | Director |
Sep 02 '26 |
Sale |
44.78 |
39,265 |
1,758,145 |
15,660 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):